AAAAAA
Results:
1-13
|
Results: 13
Authors:
Vilquin, JT
Kennel, PF
Paturneau-Jouas, M
Chapdelaine, P
Boissel, N
Delaere, P
Tremblay, JP
Scherman, D
Fiszman, MY
Schwartz, K
Citation: Jt. Vilquin et al., Electro transfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies, GENE THER, 8(14), 2001, pp. 1097-1107
Authors:
Menasche, P
Hagege, AA
Scorsin, M
Pouzet, B
Desnos, M
Duboc, D
Schwartz, K
Vilquin, JT
Marolleau, JP
Citation: P. Menasche et al., Myoblast transplantation for heart failure, LANCET, 357(9252), 2001, pp. 279-280
Authors:
Pouzet, B
Ghostine, S
Vilquin, JT
Garcin, I
Scorsin, M
Hagege, AA
Duboc, D
Schwartz, K
Menasche, P
Citation: B. Pouzet et al., Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors?, CIRCULATION, 104(12), 2001, pp. I223-I228
Authors:
Menasche, P
Hagege, A
Scorsin, M
Pouzet, B
Desnos, M
Duboc, D
Schwartz, K
Vilquin, JT
Marolleau, JP
Citation: P. Menasche et al., Autologous skeletal myoblast transplantation for cardiac failure. First clinical case report., ARCH MAL C, 94(3), 2001, pp. 180-182
Authors:
Pouzet, B
Vilquin, JT
Hagege, AA
Scorsin, M
Messas, E
Fiszman, M
Schwartz, K
Menasche, P
Citation: B. Pouzet et al., Factors affecting functional outcome after autologous skeletal myoblast transplantation, ANN THORAC, 71(3), 2001, pp. 844-850
Authors:
Tardif-de Gery, S
Vilquin, JT
Carlier, P
Raynaud, JS
Wary, C
Schwartz, K
Leroy-Willig, A
Citation: S. Tardif-de Gery et al., Muscular transverse relaxation time measurement by magnetic resonance imaging at 4 Tesla in normal and dystrophic dy/dy and dy(2j)/dy(2j) mice, NEUROMUSC D, 10(7), 2000, pp. 507-513
Authors:
Vilquin, JT
Vignier, N
Tremblay, JP
Engvall, E
Schwartz, K
Fiszman, M
Citation: Jt. Vilquin et al., Identification of homozygous and heterozygous dy(2J) mice by PCR, NEUROMUSC D, 10(1), 2000, pp. 59-62
Authors:
Chapdelaine, P
Moisset, PA
Campeau, P
Asselin, I
Vilquin, JT
Tremblay, JP
Citation: P. Chapdelaine et al., Functional EGFP-dystrophin fusion proteins for gene therapy vector development, PROTEIN ENG, 13(9), 2000, pp. 611-615
Authors:
Scorsin, M
Hagege, A
Vilquin, JT
Fiszman, M
Marotte, F
Samuel, JL
Rappaport, L
Schwartz, K
Menasche, P
Citation: M. Scorsin et al., Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function, J THOR SURG, 119(6), 2000, pp. 1169-1175
Authors:
Pouzet, B
Vilquin, JT
Hagege, AA
Scorsin, M
Messas, E
Fiszman, M
Schwartz, K
Menasche, P
Citation: B. Pouzet et al., Intramyocardial transplantation of autologous myoblasts - Can tissue processing be optimized?, CIRCULATION, 102(19), 2000, pp. 210-215
Authors:
Vilquin, JT
Guerette, B
Puymirat, J
Yaffe, D
Tome, FMS
Fardeau, M
Fiszman, M
Schwartz, K
Tremblay, JP
Citation: Jt. Vilquin et al., Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles, GENE THER, 6(5), 1999, pp. 792-800
Authors:
Kuang, W
Xu, H
Vilquin, JT
Engvall, E
Citation: W. Kuang et al., Activation of the lama2 gene in muscle regeneration: Abortive regenerationin laminin alpha 2-deficiency, LAB INV, 79(12), 1999, pp. 1601-1613
Transplantation of human myoblasts in SCID mice as a potential muscular model for myotonic dystrophy
Authors:
Skuk, D
Furling, D
Bouchard, JP
Goulet, M
Roy, B
Lacroix, Y
Vilquin, JT
Tremblay, JP
Puymirat, J
Citation: D. Skuk et al., Transplantation of human myoblasts in SCID mice as a potential muscular model for myotonic dystrophy, J NE EXP NE, 58(9), 1999, pp. 921-931
Risultati:
1-13
|